193 related articles for article (PubMed ID: 33911377)
1. Clinical Spectrum, Therapeutic Outcomes and Prognostic predictors in Paraneoplastic Neurological Syndromes - Experiences from a Tertiary Care Center in India.
Vijayaraghavan A; Alexander PT; Nair AV; Sivadasan A; Mani AM; Mathew D; Shaikh A; Benjamin RN; Prabhakar AT; Jude J; Mani S; Aaron S; Mathew V; Alexander M
Ann Indian Acad Neurol; 2021; 24(1):32-39. PubMed ID: 33911377
[TBL] [Abstract][Full Text] [Related]
2. "Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expected.
Berger B; Bischler P; Dersch R; Hottenrott T; Rauer S; Stich O
J Neurol Sci; 2015 May; 352(1-2):58-61. PubMed ID: 25824848
[TBL] [Abstract][Full Text] [Related]
3. A single center retrospective study of paraneoplastic neurological syndromes with positive onconeural antibodies.
Fu P; He L; Tang N; Nie Q; Li Z
J Clin Neurosci; 2021 Jul; 89():336-342. PubMed ID: 34119290
[TBL] [Abstract][Full Text] [Related]
4. Paraneoplastic neurological syndromes with onconeural antibodies: A single center retrospective study.
Oliveira V; Videira G; Samões R; Carneiro P; Neves E; Santos E
J Neurol Sci; 2020 Nov; 418():117103. PubMed ID: 32877801
[TBL] [Abstract][Full Text] [Related]
5. [Clinical characteristics of "classical" and "non-classical" paraneoplastic neurological syndrome].
Lyu XY; Wang GP; Tang QQ; Cheng ZZ; Gui W; Tian YH
Zhonghua Yi Xue Za Zhi; 2021 Mar; 101(9):615-619. PubMed ID: 33685041
[No Abstract] [Full Text] [Related]
6. Paraneoplastic neurological syndromes of the central nervous system: a single institution 7-year case series.
Giammello F; Galletta K; Grillo F; Brizzi T; Cavallaro M; Mormina E; Scelzo E; Allegra C; Stancanelli C; Rodolico C; Musumeci O; Toscano A; Granata F
Acta Neurol Belg; 2023 Aug; 123(4):1355-1369. PubMed ID: 36884202
[TBL] [Abstract][Full Text] [Related]
7. Paraneoplastic Neurological Syndromes as Initial Presentation of Tumors: An Eight-Year Single-Center Experience.
Melanis K; Stefanou MI; Kitsos DK; Athanasaki A; Theodorou A; Koropouli E; Keramida A; Dimitriadou EM; Tzanetakos D; Andreadou E; Koutroulou I; Giannopoulos S; Paraskevas GP; Tsivgoulis G; Tzartos JS
J Clin Med; 2024 Jan; 13(3):. PubMed ID: 38337520
[TBL] [Abstract][Full Text] [Related]
8. Spectrum of paraneoplastic neurologic disorders in women with breast and gynecologic cancer.
Rojas-Marcos I; Rousseau A; Keime-Guibert F; Reñé R; Cartalat-Carel S; Delattre JY; Graus F
Medicine (Baltimore); 2003 May; 82(3):216-23. PubMed ID: 12792307
[TBL] [Abstract][Full Text] [Related]
9. Anti-Ma2 Antibody-Associated Paraneoplastic Neurological Syndromes: A Pilot Study.
Guo Y; Cai MT; Lai QL; Zheng Y; Shen CH; Zhang YX
Brain Sci; 2021 Nov; 11(12):. PubMed ID: 34942879
[TBL] [Abstract][Full Text] [Related]
10. Paraneoplastic antigens as biomarkers for early diagnosis of ovarian cancer.
Chatterjee M; Hurley LC; Tainsky MA
Gynecol Oncol Rep; 2017 Aug; 21():37-44. PubMed ID: 28653032
[TBL] [Abstract][Full Text] [Related]
11. Neurological paraneoplastic syndromes in lung cancer patients.
Stefens-Stawna P; Piorunek T; Gabryel-Batura H; Kozubski W; Michalak S
Adv Exp Med Biol; 2013; 756():333-9. PubMed ID: 22836651
[TBL] [Abstract][Full Text] [Related]
12. [Neurological syndromes, encephalitis].
Yamamoto T; Tsuji S
Gan To Kagaku Ryoho; 2010 Jun; 37(6):995-1005. PubMed ID: 20567100
[TBL] [Abstract][Full Text] [Related]
13. Onconeural antibodies in patients with neurological symptoms: detection and clinical significance.
Raspotnig M; Vedeler CA; Storstein A
Acta Neurol Scand Suppl; 2011; (191):83-8. PubMed ID: 21711262
[TBL] [Abstract][Full Text] [Related]
14. Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.
Ariño H; Höftberger R; Gresa-Arribas N; Martínez-Hernández E; Armangue T; Kruer MC; Arpa J; Domingo J; Rojc B; Bataller L; Saiz A; Dalmau J; Graus F
JAMA Neurol; 2015 Aug; 72(8):874-81. PubMed ID: 26099072
[TBL] [Abstract][Full Text] [Related]
15. Intrathecal synthesis of onconeural antibodies in patients with paraneoplastic syndromes.
Corsini E; Gaviani P; Chiapparini L; Lazzaroni M; Ciusani E; Bisogno R; Silvani A; Salmaggi A; Bernardi G
J Neuroimmunol; 2016 Jan; 290():119-22. PubMed ID: 26711581
[TBL] [Abstract][Full Text] [Related]
16. Paraneoplastic neurological syndromes in lung cancer patients with or without onconeural antibodies.
Raspotnig M; Vedeler C; Storstein A
J Neurol Sci; 2015 Jan; 348(1-2):41-5. PubMed ID: 25467140
[TBL] [Abstract][Full Text] [Related]
17. Parkinsonism and dysautonomia with anti-CV2/CRMP5 associated paraneoplastic neurological syndromes mimicking multiple system atrophy: a case report.
Song J; Zhang Y; Lang Y; Wang YH; Shao J; Cui L
BMC Neurol; 2021 Oct; 21(1):408. PubMed ID: 34702214
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer, Hu antibodies and paraneoplastic neurological syndromes.
Storstein A; Raspotnig M; Vitaliani R; Giometto B; Graus F; Grisold W; Honnorat J; Vedeler CA
J Neurol; 2016 May; 263(5):1001-1007. PubMed ID: 27007485
[TBL] [Abstract][Full Text] [Related]
19. Paraneoplastic neurologic syndromes in children: a review article.
Alavi S
Iran J Child Neurol; 2013; 7(3):6-14. PubMed ID: 24665300
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of paraneoplastic neurological syndromes: a population-based study.
Vogrig A; Gigli GL; Segatti S; Corazza E; Marini A; Bernardini A; Valent F; Fabris M; Curcio F; Brigo F; Iacono D; Passadore P; Rana M; Honnorat J; Valente M
J Neurol; 2020 Jan; 267(1):26-35. PubMed ID: 31552550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
